Last reviewed · How we verify

NCT04990401: BAT

Behavioral Activation Teletherapy to Increase Physical Activity

Completed NA Last updated 23 December 2025
What this trial tests

NA trial testing Behavioral Activation Teletherapy in Depression in 65 participants. Completed in 31 May 2025.

Timeline
31 August 2021
Primary endpoint
30 May 2025
31 May 2025

Quick facts

Lead sponsorUniversity of Texas Southwestern Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment65
Start date31 August 2021
Primary completion30 May 2025
Estimated completion31 May 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Texas Southwestern Medical Center

Who can join

Adults 18 to 64, any sex, with Depression or Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a pilot study of acceptability, feasibility, and preliminary efficacy of a brief, 10-session Behavioral Activation intervention delivered via teletherapy to increase physical activity and treat depressive symptoms.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Pilot evaluation on an adapted tele-behavioral activation to increase physical activity in persons with depression: a single-arm pilot study.
    Rethorst CD, Trombello JM, Chen PM, Carmody TJ, et al · · 2024 · cited 1× · PMID 39522018 · DOI 10.1186/s40359-024-02053-5

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

Other University of Texas Southwestern Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04990401.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing